Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma

NCT04108377 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Enrollment stopped secondary to completion of funding

Conditions

Asthma

Interventions

DRUG: Roflumilast
DRUG: Placebo

Sponsor

University of California, Davis